givinostat: Clinical Trials

4 trials of givinostat, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting, 1 completed. 4 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 34Recruiting 3, Completed 1
Phase 21Recruiting 1

Follow givinostat: new trials by email Literature Review of givinostat trials Research Report on givinostat

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera
Givinostat, Hydroxyurea - Polycythemia Vera
Phase 3RecruitingItalfarmaco2202024-03-262026-03-25
Efficacy, Safety and Tolerability of Givinostat in Non-ambulant Patients With Duchenne Muscular Dystrophy
Givinostat, Placebo - Duchenne Muscular Dystrophy
Phase 3RecruitingItalfarmaco1382024-02-192026-07-24
Givinostat in Duchenne's Muscular Dystrophy Long-term Safety and Tolerability Study
Givinostat - Duchenne Muscular Dystrophy
Phase 2 / Phase 3RecruitingItalfarmaco2062017-10-242026-01-21
Clinical Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Duchenne Muscular Dystrophy
givinostat, placebo - Duchenne Muscular Dystrophy
Phase 3CompletedItalfarmaco1792017-06-062023-02-02

Conditions studied

Muscular Dystrophy, Duchenne (3)  ·  Polycythemia Vera (1)

Sponsors

Italfarmaco (4)

Countries

France (4)  ·  Germany (4)  ·  Italy (4)  ·  Netherlands (4)  ·  Serbia (4)  ·  Spain (4)  ·  United Kingdom (4)  ·  Belgium (3)  ·  Canada (3)  ·  Israel (3)  ·  United States (3)  ·  Poland (2)  ·  Austria (1)  ·  Bulgaria (1)  ·  Croatia (1)

Top investigators

Eugenio Mercuri, MD, PhD (1)

Results publications

PMID 38508835, PMID 40830818

NIH funding

2016 (1), 2023 (1)